Literature DB >> 20503061

Pulmonary involvement in early rheumatoid arthritis patients.

Hisham M Habib1, Ashraf A Eisa, Waleed R Arafat, Mohamed A Marie.   

Abstract

Pulmonary involvement in rheumatoid arthritis (RA) is common and can be due to the disease itself as well as to the therapies used to treat it. The purpose of this study was to disclose the pulmonary involvement in early RA patients not more than 2 years disease duration using the computed tomography (CT) as well as the pulmonary function tests as ways of pulmonary involvement assessment. Forty patients aged 37.6 ± 10.3 with early rheumatoid arthritis not more than 2 years of disease duration were recruited for the study. All patients were assessed clinically for their RA with DAS28, which was utilized for disease activity determination. Ten percent of our patients were found to be clinically involved by interstitial lung disease (ILD), where 27% have abnormal HRCT finding and 32.5% with abnormal PFT. Predilection for clinically manifest ILD was evident in active RA patients with high DAS28 score, seropositive RA patients, and in patients receiving steroids and anti-TNFα therapy. ILD occurs early in the course of RA, with more predilection for clinically active RA disease.

Entities:  

Mesh:

Year:  2010        PMID: 20503061     DOI: 10.1007/s10067-010-1492-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  20 in total

1.  Pulmonary function and high-resolution CT findings in patients with an inherited form of pulmonary fibrosis, Hermansky-Pudlak syndrome, due to mutations in HPS-1.

Authors:  M Brantly; N A Avila; V Shotelersuk; C Lucero; M Huizing; W A Gahl
Journal:  Chest       Date:  2000-01       Impact factor: 9.410

2.  Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society.

Authors: 
Journal:  Am Rev Respir Dis       Date:  1991-11

3.  Airway obstruction and rheumatoid arthritis.

Authors:  A Vergnenègre; N Pugnere; M T Antonini; M Arnaud; B Melloni; R Treves; F Bonnaud
Journal:  Eur Respir J       Date:  1997-05       Impact factor: 16.671

4.  The Health Assessment Questionnaire (HAQ).

Authors:  B Bruce; J F Fries
Journal:  Clin Exp Rheumatol       Date:  2005 Sep-Oct       Impact factor: 4.473

5.  Thin-section CT findings in rheumatoid arthritis-associated lung disease: CT patterns and their courses.

Authors:  M Akira; M Sakatani; H Hara
Journal:  J Comput Assist Tomogr       Date:  1999 Nov-Dec       Impact factor: 1.826

6.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Authors:  M L Prevoo; M A van 't Hof; H H Kuper; M A van Leeuwen; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1995-01

7.  Extra-articular manifestations of seronegative and seropositive rheumatoid arthritis.

Authors:  Vjollca Sahatciu-Meka; Sylejman Rexhepi; Suzana Manxhuka-Kerliu; Mjellma Rexhepi
Journal:  Bosn J Basic Med Sci       Date:  2010-02       Impact factor: 3.363

8.  Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria.

Authors:  J Fransen; M C W Creemers; P L C M Van Riel
Journal:  Rheumatology (Oxford)       Date:  2004-07-06       Impact factor: 7.580

9.  Respiratory symptoms in rheumatoid arthritis: relation between high resolution CT findings and functional impairment.

Authors:  Hiroshi Terasaki; Kiminori Fujimoto; Naofumi Hayabuchi; Yoshio Ogoh; Takaaki Fukuda; Nestor L Müller
Journal:  Radiat Med       Date:  2004 May-Jun

Review 10.  Pulmonary manifestations of rheumatoid arthritis.

Authors:  L T Tanoue
Journal:  Clin Chest Med       Date:  1998-12       Impact factor: 2.878

View more
  26 in total

Review 1.  Interstitial Lung Disease in Elderly Rheumatoid Arthritis Patients.

Authors:  Riccardo Messina; Giuliana Guggino; Alida Benfante; Nicola Scichilone
Journal:  Drugs Aging       Date:  2020-01       Impact factor: 3.923

Review 2.  Methotrexate-induced pulmonary toxicity in psoriatic arthritis (PsA): case presentation and literature review.

Authors:  Federico Rondon; Odilio Mendez; Nestor Spinel; Carlos Ochoa; Cristian Saavedra; Edgar Penaranda; Ignacio Garcia-Valladares; Luis R Espinoza; Antonio Iglesias-Gamarra
Journal:  Clin Rheumatol       Date:  2011-05-26       Impact factor: 2.980

3.  Baseline Characteristics and Progression of a Spectrum of Interstitial Lung Abnormalities and Disease in Rheumatoid Arthritis.

Authors:  Leticia Kawano-Dourado; Tracy J Doyle; Karina Bonfiglioli; Márcio V Y Sawamura; Renato H Nakagawa; Fábio E Arimura; Hye J Lee; Diana Arrais de Souza Rangel; Cleonice Bueno; Carlos R R Carvalho; Maria Laura Sabbag; Camila Molina; Ivan O Rosas; Ronaldo A Kairalla
Journal:  Chest       Date:  2020-05-16       Impact factor: 9.410

Review 4.  Treatment of rheumatoid arthritis-associated interstitial lung disease: a perspective review.

Authors:  Kundan Iqbal; Clive Kelly
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-12       Impact factor: 5.346

5.  Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Prospective Cohort Study.

Authors:  Jeffrey A Sparks; Xintong He; Jie Huang; Elaine A Fletcher; Alessandra Zaccardelli; H Maura Friedlander; Ritu R Gill; Hiroto Hatabu; Mizuki Nishino; David J Murphy; Christine K Iannaccone; Taysir G Mahmoud; Michelle L Frits; Bing Lu; Ivan O Rosas; Paul F Dellaripa; Michael E Weinblatt; Elizabeth W Karlson; Nancy A Shadick; Tracy J Doyle
Journal:  Arthritis Rheumatol       Date:  2019-08-04       Impact factor: 10.995

6.  Nintedanib reduces pulmonary fibrosis in a model of rheumatoid arthritis-associated interstitial lung disease.

Authors:  Elizabeth F Redente; Martin A Aguilar; Bart P Black; Benjamin L Edelman; Ali N Bahadur; Stephen M Humphries; David A Lynch; Lutz Wollin; David W H Riches
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-03-15       Impact factor: 5.464

Review 7.  Interstitial lung disease in patients with rheumatoid arthritis: spontaneous and drug induced.

Authors:  Robert W Hallowell; Maureen R Horton
Journal:  Drugs       Date:  2014-03       Impact factor: 9.546

8.  Rheumatoid arthritis-related lung disease detected on clinical chest computed tomography imaging: Prevalence, risk factors, and impact on mortality.

Authors:  Sicong Huang; Tracy J Doyle; Mark M Hammer; Suzanne C Byrne; Weixing Huang; Allison A Marshall; Christine K Iannaccone; Jie Huang; Vivi Feathers; Michael E Weinblatt; Paul F Dellaripa; Nancy A Shadick; Jeffrey A Sparks
Journal:  Semin Arthritis Rheum       Date:  2020-09-28       Impact factor: 5.532

Review 9.  Rheumatoid arthritis-associated interstitial lung disease: an overview of epidemiology, pathogenesis and management.

Authors:  Yujie Dai; Weina Wang; Yikai Yu; Shaoxian Hu
Journal:  Clin Rheumatol       Date:  2020-08-13       Impact factor: 2.980

10.  Preclinical lung disease in early rheumatoid arthritis.

Authors:  Alejandro Robles-Perez; Patricio Luburich; Benigno Rodriguez-Sanchon; Jordi Dorca; Joan Miquel Nolla; Maria Molina-Molina; Javier Narvaez-Garcia
Journal:  Chron Respir Dis       Date:  2016-02       Impact factor: 2.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.